Particle.news

Download on the App Store

UVA Identifies Cyclooxygenase-1 in Microglia as Key to Brain Capillary Flow

By pinpointing cyclooxygenase-1’s control over capillary tone, UVA has launched a translational research center to pioneer microglia-targeted therapies for neurodegenerative diseases.

Image
Image

Overview

  • Nature Communications study led by Ukpong B. Eyo provides definitive in vivo proof that microglia regulate cerebral capillary basal tone via cyclooxygenase-1.
  • Experimental depletion of microglia in mice reduced capillary diameter and blood perfusion, and restoring microglia reversed these deficits.
  • The identification of microglial cyclooxygenase-1 as the modulator of capillary tone highlights a new avenue for boosting brain blood flow in Alzheimer’s and related disorders.
  • UVA has established the Harrison Family Translational Research Center to translate these insights into microglia-focused neurodegenerative treatments.
  • Upcoming research will explore optimal intervention windows and microglia-cell interactions to guide the development of blood flow–enhancing therapies.